Key result
Thoracic epidural analgesia combined with general anaesthesia significantly reduced 36-month mortality to 16.9% compared to 28.0% with general anaesthesia alone after colon cancer surgery.
Why the study?
Basic science data support that regional anaesthesia reduces perioperative stress levels, potentially lowering complications and cancer relapse, but its effect on outcomes after colon cancer surgery required evaluation.
Does general anaesthesia plus thoracic epidural analgesia reduce mortality in patients undergoing open colon cancer surgery compared to general anaesthesia alone?
Cohort (n=215)
No
Does general anaesthesia plus thoracic epidural analgesia reduce mortality in patients undergoing open colon cancer surgery compared to general anaesthesia alone?
Absolute Event Rate: 16.9% vs 28%
p-value: p=<0.05
Perioperative use of thoracic epidural analgesia in addition to general anaesthesia may reduce 36-month mortality in patients undergoing open colon cancer surgery, particularly in those over 70 years of age.
Associated with lower 36-month mortality after colon cancer surgery; hypothesis-generating and should not change practice without randomized confirmation.
Background: Colorectal cancer is a major cause of death in the industrial world. The mortality and morbidity rates depend on the incidence of postoperative complications and cancer recurrence. Data from basic science support the view that regional anaesthesia reduces perioperative stress levels, potentially resulting in a lower risk of complications and cancer relapse. Methods: In 215 patients underwent open colon cancer surgery, carried out by the same visceral surgeon and the same oncologist we compared short and long-term outcome data for 83 patients with general anaesthesia plus thoracic epidural analgesia (EPI group) and for 132 patients with general anaesthesia alone (GA group). Oncological data from a state-wide follow-up database were included. The effects of different perioperative anaesthetic techniques on patients’ short and long-term outcome (36 month) were statistically analysed (Kaplan Meyer Curve, Pearson’s chi-squared test, Student’s t-test, and the Wilcoxon rank sum test, as appropriate). Results: With the exception of a significantly higher prevalence of arterial hypertension in the EPI group in comparison with the GA group, there were no differences in demographic, tumour staging data and cancer recurrence rates between the groups. However, mortality rates were significantly different between the groups. 37 of 132 GA patients (28%) died within 36 months, in comparison with 14 of 83 EPI patients (16.9%, P < 0.05). Patients over the age of 70 in particular significantly benefited from perioperative epidural analgesia and had a significantly better survival compared with patients without perioperative epidural analgesia (p<0.05). Discussion: Perioperative use of epidural analgesia reduces the 36-month postoperative mortality rate. This effect may be due to systemic effects of local anaesthetics or to a reduced stress response caused by the thoracic epidural analgesia itself. Conclusions: Patients with colon cancer over the age of 70 in particular significantly benefited from perioperative epidural analgesia and had a longer survival time in comparison with patients without perioperative epidural analgesia. (ISRCTN10994336, retrospective registered 07/06/2019)
No takes yet. Share an insight, caveat, or question.
Moormann et al. (2019) conducted a cohort in Colon cancer (n=215). Thoracic epidural analgesia combined with general anaesthesia vs. General anaesthesia alone was evaluated on 36-month mortality (p=<0.05). Thoracic epidural analgesia combined with general anaesthesia significantly reduced 36-month mortality to 16.9% compared to 28.0% with general anaesthesia alone after colon cancer surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: